SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001185185-17-001576
Filing Date
2017-07-21
Accepted
2017-07-20 21:41:46
Documents
16

Document Format Files

Seq Description Document Type Size
1 S-1 genprex-s1.htm S-1 2031716
2 EX-23.1 ex23-1.htm EX-23.1 2206
3 effectoftusc2.jpg GRAPHIC 2383013
4 metabolictum.jpg GRAPHIC 88062
5 nanovesicle.jpg GRAPHIC 74268
6 patientcell-a.jpg GRAPHIC 486629
7 patientcell-b.jpg GRAPHIC 308848
8 preclinical.jpg GRAPHIC 676322
9 rdpipeline.jpg GRAPHIC 161777
10 subjectwith.jpg GRAPHIC 72717
11 therapeutic.jpg GRAPHIC 4742838
12 tusc2erlotin.jpg GRAPHIC 293798
13 tusc2erlotinibin.jpg GRAPHIC 273407
14 tusc2modul.jpg GRAPHIC 46373
15 tusc2pan.jpg GRAPHIC 94794
16 tusc2stim.jpg GRAPHIC 102842
  Complete submission text file 0001185185-17-001576.txt   15539653
Mailing Address 3300 BEE CAVE ROAD STE 650, NO. 227 AUSTIN TX 78746
Business Address 3300 BEE CAVE ROAD STE 650, NO. 227 AUSTIN TX 78746 512-681-3709
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 264598633 | State of Incorp.: DE | Fiscal Year End: 1213
Type: S-1 | Act: 33 | File No.: 333-219386 | Film No.: 17975400
SIC: 2834 Pharmaceutical Preparations